These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35929466)

  • 1. Repeated Measures of Modified Rankin Scale Scores to Assess Functional Recovery From Stroke: AFFINITY Study Findings.
    Chye A; Hackett ML; Hankey GJ; Lundström E; Almeida OP; Gommans J; Dennis M; Jan S; Mead GE; Ford AH; Beer CE; Flicker L; Delcourt C; Billot L; Anderson CS; Stibrant Sunnerhagen K; Yi Q; Bompoint S; Nguyen TH; Lung T
    J Am Heart Assoc; 2022 Aug; 11(16):e025425. PubMed ID: 35929466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration.
    Hankey GJ; Hackett ML; Almeida OP; Flicker L; Mead GE; Dennis MS; Etherton-Beer C; Ford AH; Billot L; Jan S; Lung T; Lundström E; Sunnerhagen KS; Anderson CS; Thang-Nguyen H; Gommans J; Yi Q;
    Stroke; 2021 Aug; 52(8):2502-2509. PubMed ID: 34015940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial.
    AFFINITY Trial Collaboration
    Lancet Neurol; 2020 Aug; 19(8):651-660. PubMed ID: 32702334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression Outcomes Among Patients Treated With Fluoxetine for Stroke Recovery: The AFFINITY Randomized Clinical Trial.
    Almeida OP; Hankey GJ; Ford A; Etherton-Beer C; Flicker L; Hackett M;
    JAMA Neurol; 2021 Sep; 78(9):1072-1079. PubMed ID: 34338714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials.
    Mead G; Hackett ML; Lundström E; Murray V; Hankey GJ; Dennis M
    Trials; 2015 Aug; 16():369. PubMed ID: 26289352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm.
    Chen X; Li J; Anderson CS; Lindley RI; Hackett ML; Robinson T; Lavados PM; Wang X; Arima H; Chalmers J; Delcourt C;
    Int J Stroke; 2021 Feb; 16(2):222-228. PubMed ID: 31969072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Fluoxetine on Outcomes at 12 Months After Acute Stroke: Results From EFFECTS, a Randomized Controlled Trial.
    Lundström E; Isaksson E; Greilert Norin N; Näsman P; Wester P; Mårtensson B; Norrving B; Wallén H; Borg J; Hankey GJ; Hackett ML; Mead GE; Dennis MS; Sunnerhagen KS
    Stroke; 2021 Oct; 52(10):3082-3087. PubMed ID: 34465201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical and health economic analysis plan for the trials and for the individual patient data meta-analysis.
    Graham C; Lewis S; Forbes J; Mead G; Hackett ML; Hankey GJ; Gommans J; Nguyen HT; Lundström E; Isaksson E; Näsman P; Rudberg AS; Dennis M
    Trials; 2017 Dec; 18(1):627. PubMed ID: 29282099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine for stroke recovery improvement - the doubleblind, randomised placebo-controlled FOCUS-Poland trial.
    Bembenek JP; Niewada M; Kłysz B; Mazur A; Kurczych K; Głuszkiewicz M; Członkowska A
    Neurol Neurochir Pol; 2020; 54(6):544-551. PubMed ID: 33373036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measures Associated With Early, Late, and Persistent Clinically Significant Symptoms of Depression 1 Year After Stroke in the AFFINITY Trial.
    Almeida OP; Hankey GJ; Ford AH; Etherton-Beer C; Flicker L; Hackett ML;
    Neurology; 2022 Mar; 98(10):e1021-e1030. PubMed ID: 35042738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
    Marquez-Romero JM; Arauz A; Ruiz-Sandoval JL; Cruz-Estrada Ede L; Huerta-Franco MR; Aguayo-Leytte G; Ruiz-Franco A; Silos H
    Trials; 2013 Mar; 14():77. PubMed ID: 23510124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke: The ENCHANTED Trial.
    Chen X; Wang X; Delcourt C; Li J; Arima H; Hackett ML; Robinson T; Lavados PM; Lindley RI; Chalmers J; Anderson CS;
    Stroke; 2020 Feb; 51(2):588-593. PubMed ID: 31822251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke.
    Chalos V; van der Ende NAM; Lingsma HF; Mulder MJHL; Venema E; Dijkland SA; Berkhemer OA; Yoo AJ; Broderick JP; Palesch YY; Yeatts SD; Roos YBWEM; van Oostenbrugge RJ; van Zwam WH; Majoie CBLM; van der Lugt A; Roozenbeek B; Dippel DWJ;
    Stroke; 2020 Jan; 51(1):282-290. PubMed ID: 31795895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLUORESCE: A Pilot Randomized Clinical Trial of Fluoxetine for Vision Recovery After Acute Ischemic Stroke.
    Schneider CL; Prentiss EK; Busza A; Williams ZR; Mahon BZ; Sahin B
    J Neuroophthalmol; 2023 Jun; 43(2):237-242. PubMed ID: 36166771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome: Pooled Analysis of 20 000+ Patients.
    Wang X; Moullaali TJ; Li Q; Berge E; Robinson TG; Lindley R; Zheng D; Delcourt C; Arima H; Song L; Chen X; Yang J; Chalmers J; Anderson CS; Sandset EC
    Stroke; 2020 Aug; 51(8):2411-2417. PubMed ID: 32640944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study.
    Chen CL; Young SH; Gan HH; Singh R; Lao AY; Baroque AC; Chang HM; Hiyadan JH; Chua CL; Advincula JM; Muengtaweepongsa S; Chan BP; de Silva HA; Towanabut S; Suwanwela NC; Poungvarin N; Chankrachang S; Wong KS; Eow GB; Navarro JC; Venketasubramanian N; Lee CF; Bousser MG;
    Stroke; 2013 Aug; 44(8):2093-100. PubMed ID: 23780952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
    Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
    Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial.
    van der Ende NAM; Roozenbeek B; Berkhemer OA; Koudstaal PJ; Boiten J; van Dijk EJ; Roos YBWEM; van Oostenbrugge RJ; Majoie CBLM; van Zwam W; Lingsma HF; van der Lugt A; Dippel DWJ;
    Stroke; 2022 Jan; 53(1):61-69. PubMed ID: 34607469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Dextroamphetamine on Poststroke Motor Recovery: A Randomized Clinical Trial.
    Goldstein LB; Lennihan L; Rabadi MJ; Good DC; Reding MJ; Dromerick AW; Samsa GP; Pura J
    JAMA Neurol; 2018 Dec; 75(12):1494-1501. PubMed ID: 30167675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine and Fractures After Stroke: Exploratory Analyses From the FOCUS Trial.
    Dennis M; Forbes J; Graham C; Hackett ML; Hankey GJ; House A; Lewis S; Lundström E; Sandercock P; Mead G
    Stroke; 2019 Nov; 50(11):3280-3282. PubMed ID: 31426731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.